http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010043716-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20010043716-A
titleOfInvention Dhea composition and method
abstract The present invention is directed to an improved pharmaceutical formulation comprising dehydroepiandrosterone (DHEA) concentrated in selected polymorphic forms for use in the therapeutic field. In one embodiment, the formulation comprises at least 85% solid DHEA and one or more pharmaceutical excipients present as one polymorph selected from Form I polymorph or Form II polymorph. The present invention also relates to methods of making and using such compositions.
priorityDate 1999-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22111459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491336
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID540877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5881
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15196
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411555350
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ62588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506651
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0EQL2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452848371
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416001507
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID509206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549337
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20905
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490676
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08689
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553117
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP97497
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20415
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6128

Total number of triples: 73.